An individual patient data analysis of these trials was planned , before their results were known , to assess the effect of aspirin versus placebo on recurrent VTE , major vascular events ( recurrent VTE , myocardial infarction , stroke , and cardiovascular disease death ) and bleeding , overall and within predefined subgroups .